Externalities of Wholesale Level Regulation under Pharmaceutical Parallel Trade
Economics Bulletin, 2017, vol. 37, issue 3, 2260-2273
This paper studies the effect of pharmaceutical regulation at the wholesale level under parallel trade, i.e. trade outside the manufacturer's authorized distribution channel. In a symmetric equilibrium, both maximum wholesale margins (restriction of pricing by the intermediary) and manufacturer discounts (restriction of the pricing by the manufacturer) decrease the drug price in the respective country. Instruments differ in their effect on the other country: Whereas maximum wholesale margins increase the drug price in the other country, manufacturer discounts may decrease it.
Keywords: parallel trade; pharmaceutical regulation; externalities (search for similar items in EconPapers)
JEL-codes: F1 I1 (search for similar items in EconPapers)
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:ebl:ecbull:eb-16-00227
Access Statistics for this article
More articles in Economics Bulletin from AccessEcon
Bibliographic data for series maintained by John P. Conley ().